v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenue under licensing agreements $ 0 $ 925
Operating expenses:    
Research and development expenses 75,011 60,917
General and administrative expenses 28,317 22,613
Total operating expenses 103,328 83,530
Loss from operations (103,328) (82,605)
Other income (expense):    
Interest income 11,547 8,467
Interest expense (5) (12)
Other income 1,665 574
Other expense (230) (1,568)
Net loss $ (90,351) $ (75,144)
Per share information    
Net loss per share, basic (in dollars per share) $ (4.24) $ (4.28)
Net loss per share, diluted (in dollars per share) $ (4.24) $ (4.28)
Weighted-average shares of common stock outstanding, basic (in shares) 21,326,283 17,567,082
Weighted-average shares of common stock outstanding, diluted (in shares) 21,326,283 17,567,082